Literature DB >> 21506333

[Evaluating the activity of the apoptosis-regulating genes from Bcl-2, Bax expression, and caspase-3 activity in bronchial epithelial cells in patients with asthma].

V N Mineev, I I Nesterovich, V I Trofimov, T V Kashintseva, M G Rybakova, R V Grozov.   

Abstract

The specific features of bronchial epithelial cell apoptosis in asthma were studied, by evaluating the activity of the apoptosis-regulating genes Bcl-2, Bax, and caspase-3. Fibrobronchoscopy with target biopsy of the bronchial mucosa was carried out in 21 asthmatic patients (the latter had given informed consent). The expression of Bcl-2, Bax, and CPP32 (caspase-3 activity) was determined in the bronchial epithelial cells by the immunohistochemical technique using the DAKO kits. Allergic asthma is characterized by higher Bcl-2 and lower Bax expression than non-allergic asthma and in patients receiving systemic glucocorticosteroids. The similar nature of changes was found in the analysis of the Bcl2/Bax ratio. Regardless of the type of asthma, the expression of caspase-3 was rather high. The specific features of impaired bronchial epithelial cell apoptosis in different types of asthma can determine the pathogenetic value of apoptotic disorders in the persistence of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506333

Source DB:  PubMed          Journal:  Arkh Patol        ISSN: 0004-1955


  2 in total

1.  Prioritizing Molecular Biomarkers in Asthma and Respiratory Allergy Using Systems Biology.

Authors:  Lucía Cremades-Jimeno; María Ángeles de Pedro; María López-Ramos; Joaquín Sastre; Pablo Mínguez; Ignacio Mahillo Fernández; Selene Baos; Blanca Cárdaba
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

2.  Fine Particulate Matter-Induced Exacerbation of Allergic Asthma via Activation of T-cell Immunoglobulin and Mucin Domain 1.

Authors:  Yun-Xia Zhao; Hui-Ran Zhang; Xiu-Na Yang; Yu-Hao Zhang; Shan Feng; Feng-Xue Yu; Xi-Xin Yan
Journal:  Chin Med J (Engl)       Date:  2018-10-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.